TENX

NASDAQ:TENX

Tenax Therapeutics, Inc.

  • Stock

5.73

−0.52%

−0.18

USD last updated 14/08 01:46:41

Last Close

5.91

13/08 20:00

Market Cap

6.52M

Beta: 2.17

Volume Today

20.29K

Avg: 3.72M

PE Ratio

−20.44

PFCF: −0.36

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failur...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -2500-2000-1500-1000-5002019-11-142021-05-172023-03-312024-03-282024-11-11

    Revenue (Estimate*)

    1K2K3K4K5K6K2019-11-142021-05-172023-03-312024-03-282024-11-11

    *Estimate based on analyst consensus